Purpose: We evaluated the short and long-term surgical outcomes of urinary diversion done for urinary adverse events arising from prostate radiation therapy. We hypothesized that patient characteristics are associated with complications after urinary diversion. Materials and Methods: We performed a retrospective cohort study of 100 men who underwent urinary diversion (urinary conduit or continent catheterizable pouch) due to urinary adverse events after prostate radiotherapy from 2007 to 2016 from 9 academic centers in the United States. Outcome measurements included predictors of short and long-term complications, and readmission after urinary diversion of patients who had prostate cancer treated with radiotherapy. The data were summarized using descriptive statistics and univariate associations with complications were identified with logistic regression controlling for center. Results: Mean patient age was 71 years and median time from radiotherapy to urinary diversion was 8 years. Overall 81 (81%) patients had combined modality therapy (radical prostatectomy plus radiotherapy or various combinations of radiotherapy). Grade 3a or greater Clavien-Dindo complications occurred in 31 (35%) men, including 4 deaths (4.5%). Normal weight men had more short-term complications compared to overweight (OR 4.9, 95% CI 1.3e23.1, p¼0.02) and obese men (OR 6.3, 95% CI 1.6e31.1, p¼0.009). Hospital readmission within 6 weeks of surgery occurred for 35 (38%) men. Surgery was needed to treat longterm complications after urinary diversion in 19 (22%) patients with a median followup of 16.3 months. Conclusions: Urinary diversion after prostate radiotherapy has a considerable short and long-term surgical complication rate. Urinary diversion most often cannot be avoided in these patients but appreciation of the risks allows for informed shared decision making between surgeons and patients.
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We established the morbidity and mortality of UD in patients who have severe UAEs after prostate RT. We hypothesized that preoperative patient characteristics might predict short and long-term complications after UD.
MATERIALS AND METHODS
After institutional review board approval 9 sites in the Trauma and Urologic Reconstructive Network of Surgeons (TURNSresearch.org) and the Neurogenic Bladder Research Group (NBRG.org) retrospectively reviewed and contributed data. The study period was from 2007 to 2016, which represented 50 center years (defined as the time a surgeon was at a contributing center). Exclusion criteria were pelvic malignancy other than prostate cancer and cystectomy for bladder cancer after a history of RT for prostate cancer. Operative information included type of UD, length of stay and ancillary surgical procedures at the time of UD. Men were grouped by UAE location, which included the bladder and/or outlet/urethra. Postoperative data included rehospitalization rates within 6 weeks of UD, modified Clavien-Dindo (Clavien) grading 7 of major shortterm (less than 90 days) postoperative complications (grade 3a-5) and long-term (greater than 90 days) complications requiring surgical intervention (grade 3b). Patients were classified for short-term complications by the highest Clavien complication grade.
Variables

Statistical Analysis
Clinical characteristics were summarized as number (%) for categorical variables and mean (AE SD) or median (IQR) for continuous variables. Firth's penalized logistic regression was used to test for associations between the outcomes of 1) short-term postoperative complications and 2) readmission within 6 weeks, with each demographic, preoperative and postoperative variable (tested separately) controlling for the 9 centers. ORs and 95% CIs were reported from these models. An extension of Firth's methodology to Cox regression was used for analysis of long-term complications, and HRs and 95% CIs were reported. The cohorts for analysis included short-term complicationsdpatients who died or had a minimum of 3 months of followup, readmissiondpatients who died or had a minimum of 6 weeks of followup, and long-term complicationsdpatients who survived and had more than 3 months of followup. A Kaplan-Meier plot was used to illustrate the cumulative long-term surgical complications (patients were censored after their first surgical complication). Statistical significance was assessed at a 0.05 level and all tests were 2-tailed. Analyses were conducted in R v. 3.03 software using the logistf and coxphf packages. 7 
RESULTS
Demographics
A total of 105 men were identified who underwent UD with a history of RT for prostate cancer. Four men were excluded from analysis due to concomitant pelvic cancer other than prostate cancer and 1 because he was treated with augmentation cystoplasty. The 100 men meeting the inclusion criteria had a mean age of 71.0 AE 7.9 years (range 51 to 89). Median time from RT to UD was 8 years (IQR 5e12, range 0.8 to 31). The mean estimated number of operations for RT associated UAEs before UD was 3.7 AE 2.2 (range 0 to 15). Divided in tertiles the Charlson comorbidity index was 2 to 5 in 49 men (49%), 6 in 22 (22%) and 7 or greater in 28 (28%). Overall 22% of men were normal weight, 42% overweight and 36% obese (table 1) .
Previous Radiation Therapy
Radiation therapy for prostate cancer included 19 (19%) patients who were treated with single modality therapy with RT alone and 81 (81%) who underwent combined modality therapy (table 1) .
The most common combined modality therapy was RP plus EBRT in 51 patients (51%). Prostate cryoablation was used in 10 men (2 who had single modality RT before cryotherapy and 8 who had combined modality RT before cryotherapy).
Radiation Related Urinary Adverse Events
UAEs from RT leading to UD included intractable incontinence (55%), urethral stricture/bladder neck contracture (52%), fistula or perforation (42%), urinary infection/abscess (32%), hemorrhagic cystitis (25%) and necrosis of the bladder or urethra/prostate (25%). The UAE location was urethra/outlet in 48 (48%), bladder in 7 (7%), and urethra/outlet and bladder in 45 (45%) men.
Urinary Diversion
Overall 16 (16%) patients were treated with a continent catheterizable pouch and 84 (84%) patients underwent urinary conduit (ileal conduit in 78 [93%], colon conduit in 6 [7%]). There were 83 (83%) patients who underwent cystectomy at urinary diversion. Other procedures at UD included prostatectomy (12) , bowel resection (6), fistula excision (3), artificial urinary sphincter explantation (3), gracilis flap (1), drainage of abscess (1), pubic symphysis debridement (1) and penile prosthesis explantation (1).
Short-term Complications and Readmission
There were 89 patients who had followup longer than 90 days or who died in the perioperative period. Clavien grade 3a or greater complications occurred within 90 days after UD in 31 (36%) men, including grade 3a (intervention without general anesthesia) in 3 (3%), grade 3b (reoperation) in 11 (12%), grade 4 (intensive care unit readmission for complications) in 13 (15%) and grade 5 (death) in 4 (4.5%) (table 2). Causes of death included exacerbation of end stage liver failure from a history of cholangiocarcinoma, postoperative hemorrhage, rectal perforation and septic shock. There were 13 (15%) men who underwent early reoperation (11 grade 3b and 2 additional men with higher grade complications who also required operative intervention). These 13 men underwent 16 total operations within 90 days of surgery.
The odds of a major short-term complication (Clavien 3a or greater) were 4.9 (CI 1.3e23.1, p¼0.02) and 6.3 (CI 1.6e31.1, p¼0.009) times higher in normal weight men compared to overweight or obese men, respectively. When BMI was treated as a continuous variable there was a 9% risk reduction of There were 93 men with 6 weeks of followup or more and 35 (38%) were readmitted to the hospital for postoperative complications. Using the same variables as short-term complications, the only association with a higher risk of rehospitalization was lower BMI when BMI was analyzed as a continuous variable. The rate of readmission was decreased by 11% for every 1-point increase in BMI (OR 0.89, 95% CI 0.80e0.97, p¼0.009).
Long-term Complications
A total of 15 men were excluded from the analysis of long-term complications due to death (4) or loss to followup (11) within 90 days. Median followup was 16.3 months (IQR 9.5e35.1, range 3.1 to 96.9) for the 85 men in the long-term complications analysis. Of the 85 men 19 (22%) underwent 27 surgeries for longterm complications. The Kaplan-Meier plot of the cumulative incidence of reoperation for long-term complications is shown in the figure. Reoperations are summarized in table 2. There was no association between long-term complications and the same parameters as analyzed for short-term complications.
DISCUSSION
There was a high rate of complications associated with UD performed for severe UAEs of prostate RT. These included death (less than 90 days) in 4.5%, reoperation (less than 90 days) in 15%, Clavien 3 or greater complications (less than 90 days) in 36% and hospital readmission (less than 6 weeks) in 38%. In addition, we found a high long-term surgical burden with 15% of men needing additional surgery in the first year after UD. However, UD was performed in a high risk group of men in whom all other options short of UD had failed for the management of severe UAEs after RT. Before the operation the men often experienced chronic infection, necrosis of the urinary tract and urinary fistula, likely leading to a state of malnutrition. In addition, half of the men presented with a Charlson comorbidity score greater than 5, illustrating that their overall health was poor. The only association with poor outcomes in our analysis was lower BMI, which may support nutrition as an important factor.
In the 1 study to date examining UD after prostate RT Faris et al focused on the presentation and symptom progression leading to UD. 8 In this single institution study 30 men underwent an average of 4.4 urological surgeries attempting to treat RT UAEs before UD, which was similar to our study (3.7 operations before UD). The authors did not discuss postoperative outcomes but the UAEs that led to UD were similar to those in our study (fistula, irreparable stricture/outlet pathology and radiation cystitis).
We found a higher rate of major short-term complications in normal weight men vs overweight and obese men. This might have been observed because normal weight men in this age group might not necessarily be healthier but instead have normal weight due to malnutrition resulting from their chronic disease state. An alternative explanation is the obesity paradox, where extra weight is counterintuitively protective and associated with greater survival during physiological stress, which has been demonstrated in 2 recent meta-analyses of patients in the intensive care setting. 9, 10 A high proportion of men (81%) who underwent UD in our study had combined modality therapy, the most frequent being RP and subsequent RT (51% of the entire study population). Some studies have reported that RT after RP has minimal long-term urinary consequences. 11 In contrast, other studies have reported a higher morbidity for subsequent RT after RP. EORTC trial 22911 showed 11% more UAEs (any grade) at 10 years of followup in men with RP and RT vs RP alone. 12 In addition, SEER (Surveillance, Epidemiology, and End Results)-Medicare data estimated that the 10-year incidence of grade 3e4 UAEs was 9.2% higher in patients treated with RP and RT than those treated with RP only. 13 We are unable to determine the incidence of UAEs in patients undergoing combined modality treatment for prostate cancer. However, the high rate of combined modality therapy (81%) in men needing UD intuitively indicates its increased toxicity.
In our study the high grade complication rate and mortality risk with UD was higher than that reported in contemporary series of radical cystectomy and UD for bladder cancer. 14e16 Schiavina et al reported a major complication rate of 17.3% and a 90-day mortality of 4.5%. 16 Similarly, Shabsigh et al demonstrated a major complication (Clavien grade 3e5) rate of 13% and a 90-day mortality of 2% in 1,142 patients with bladder cancer. 15 Significant predictors of major complications in these studies included ASA Ò score, age at surgery, prior abdominal surgery and estimated blood loss during surgery. 15, 16 In contrast to our patients only 30% of subjects had a Charlson comorbidity index score of 2 or greater compared to 100% of men in our study (50% Charlson comorbidity index 5 or greater), an observation that may explain why we found a higher rate of major complications (36%) and a comparable or higher perioperative mortality (4.5%) than these studies. When comparing our outcomes to other series of UD after RT, they were similar. Eisenberg et al reported on a post-RT UD series of 148 patients with 32.4% major complications and a 90-day mortality of 6.1%, which was almost identical to our results. 17 Our long-term complication rate requiring reoperation was 20% at a median followup of 16.3 months and was not associated with a specific type of UD or any other patient characteristics. Other studies have shown a high rate of long-term complications, especially among patients treated with RT and continent catheterizable diversions. One of the highest rates was in patients with cervical cancer who had RT and underwent UD with an Indiana pouch where 67% required a second operation at a mean followup of 48.5 months. 18 There is no doubt our long-term complications will increase as our followup time increases.
Some major limitations of our study are the retrospective design and referral bias, which did not allow us to determine the rate of UAEs of RT in our communities, as well as how many men experienced severe UAEs but never sought treatment with UD. Another weakness of the study is the lack of longer term followup to estimate the long-term risk of additional surgeries related to UD. We included these data even though they are limited by a median followup of 16.5 months because they illustrate that even in this short time many men require additional surgery. Our study was underpowered to detect a difference between types of UD and complications due to the predominance of conduits as well as differences in outcomes among centers. Lower BMI was associated with a higher complication rate, Kaplan-Meier plot of cumulative long-term surgical complications. Black line indicates median followup of 16.3 months, when long-term risk of surgical interventions was 20% (patients censored after first surgical complication). At 6 months cumulative operative long-term complication rate was 3.8% (95% CI 0e7.9) and 70 patients had data included in estimate. At 1 year cumulative operative long-term complication rate was 14.6% (95% CI 5.7e22.7) and 55 patients had data available.
possibly due to relative malnutrition, but better surrogates for preoperative nutrition status such as albumin, prealbumin and transferrin were not available in our retrospective review.
CONCLUSIONS
Urinary diversion in men after prostate RT has considerable short and long-term morbidity. Most men who need UD have received combined modality treatment with a long latency period between RT and UD. Normal weight men have a higher shortterm complication rate than overweight and obese men. Urinary diversion is a treatment of last resort in the majority of these men and cannot be avoided in most cases. However, understanding the true morbidity and mortality associated with this treatment allows for informed shared decisions between patients and surgeons.
